(click on the image above to view the video)

Recorded at the IMF Satellite Symposium that was held at the May 2017 Oncology Nursing Society’s annual meeting, this video is the second in a three-part series on myeloma nursing. In this segment, Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN (Taussig Cancer Insitute, Cleveland Clinic, Cleveland, OH) and Sandra Rome, RN, MN, AOCN, CNS discuss bone and renal health. 

DOWNLOAD SLIDES

 

Other Topics:

 


This activity is supported by educational grants from Celgene Corporation, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Bristol-Myers Squibb.

 

Previous Post
If I have a sustained remission and am on Revlimid, should I continue using it?
Next Post
What does it mean if my serum Beta 2-microglobulin is increased, but all other testing shows remission?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt out, click for more information.